Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e09319fe979c0d63f50e0b9dcf132ae |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2440-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2440-10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
filingDate |
2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18eaf0d902f28dc9bad4d317a8a1f8d3 |
publicationDate |
2014-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014013184-A1 |
titleOfInvention |
Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder |
abstract |
The invention relates to a pharmaceutical composition including at least one epigenome-modifying compound, for the use thereof in the treatment of genetic muscular diseases linked to a conformational anomaly of at least one protein, said anomaly leading to the cellular degradation of the protein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021130382-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3685846-A1 |
priorityDate |
2012-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |